TWD 77.8
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -337.37 Million TWD | -18.56% |
2022 | -284.57 Million TWD | 0.47% |
2021 | -285.92 Million TWD | -7.6% |
2020 | -265.74 Million TWD | -67.45% |
2019 | -158.7 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -309.94 Million TWD | 8.13% |
2024 Q2 | -400.45 Million TWD | -29.2% |
2023 Q3 | -460.86 Million TWD | -4.17% |
2023 FY | -337.37 Million TWD | -18.56% |
2023 Q1 | -292.76 Million TWD | 11.55% |
2023 Q2 | -442.43 Million TWD | -51.12% |
2023 Q4 | -337.37 Million TWD | 26.79% |
2022 Q4 | -330.98 Million TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Bio Preventive Medicine Corp. | 31.8 Million TWD | 1160.624% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 1203.323% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -424.516% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1747.093% |
NaviFUS Corp. | -123.12 Million TWD | -174.0% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -151.299% |
TaiRx, Inc. | -147.86 Million TWD | -128.157% |
Sinew Pharma Inc. | -160.34 Million TWD | -110.405% |
Lin BioScience, Inc. | -3.21 Billion TWD | 89.517% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -485.13% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 18.24% |
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -337.898% |
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -27.711% |
AP Biosciences Inc | -196.52 Million TWD | -71.667% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 50.43% |
RBC Bioscience Corporation | 422.18 Million TWD | 179.911% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 207.146% |
EirGenix Inc. | -4.58 Billion TWD | 92.647% |
Enimmune corporation | -314.15 Million TWD | -7.39% |
Lukas Biomedical Inc. | 50.75 Million TWD | 764.711% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 64.277% |
3D Global Biotech Inc. | -11.43 Million TWD | -2849.847% |
TaiMed Biologics Inc. | 499.84 Million TWD | 167.495% |
Mycenax Biotech Inc. | 207 Million TWD | 262.976% |
TCI GENE Inc. | -689.25 Million TWD | 51.052% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -28.483% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 18.681% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -61.162% |
Feng Chi Biotech Corp. | -19.81 Million TWD | -1602.791% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | -71.782% |
TWi Biotechnology, Inc. | -143.86 Million TWD | -134.511% |
Neith Corporation | -150.31 Million TWD | -124.451% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 379.119% |
VBI | -25.31 Million TWD | -1232.651% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | -2.067% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 937.863% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -232.434% |
CHO Pharma, Inc. | -203.79 Million TWD | -65.548% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -39.472% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -183.655% |
Visgeneer Inc. | 31.28 Million TWD | 1178.423% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -298.02% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 555.597% |
Sagittarius Life Science Corp | -120.57 Million TWD | -179.816% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | -6.287% |
GlycoNex Incorporation | -148.56 Million TWD | -127.085% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 148.985% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 59.337% |
PharmaEngine, Inc. | -860.8 Million TWD | 60.807% |
Intech Biopharm Corporation | 1.35 Billion TWD | 124.856% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 344.483% |
BiOptic Inc. | 12.59 Million TWD | 2779.273% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -12.47% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 74.231% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -231.181% |
OBI Pharma, Inc. | -398.22 Million TWD | 15.28% |
Savior Lifetec Corporation | -812.54 Million TWD | 58.479% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -104.251% |
Level Biotechnology Inc. | -453.9 Million TWD | 25.673% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 154.281% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 7.675% |
Acepodia, Inc. | -6.02 Billion TWD | 94.396% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 90.082% |